These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12436766)

  • 1. [Recommendations for comprehensive risk reduction for patients with coronary heart disease, vascular diseases and diabetes. Distributed by the leadership of the German Society of Cardiology-Heart- and Vascular Research. Produced by request of the Committee of Clinical Cardiology by the Prevention Project Group].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2002; 91 Suppl 2():61-2. PubMed ID: 12436766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dietary fats and atherosclerosis].
    Schwandt P
    Verh Dtsch Ges Inn Med; 1991; 97():227-38. PubMed ID: 1808891
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of coronary heart diseases in clinical practice. Comment on the recommendations of the Second Joint Task Force of European Societies for Prevention of Coronary Disease].
    Klein W; Maurer G; Patsch JR; Sandhofer F; Silberbauer K
    Wien Med Wochenschr; 1999; 149(5-6):111-8. PubMed ID: 10408001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery disease and cerebrovascular disease prevention in diabetes mellitus: early identification and aggressive modification of risk factors.
    Hennessey JV; Westrick E
    Med Health R I; 1998 Nov; 81(11):350-2. PubMed ID: 15580789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of atherosclerosis in diabetes mellitus].
    Quiroz Martínez A
    Arch Cardiol Mex; 2003; 73 Suppl 1():S125-7. PubMed ID: 12966662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk predictors and secondary prevention in angina pectoris and after myocardial infarct].
    Huber K; Hornykewycz S; Angles-Cano E
    Internist (Berl); 1995 Sep; 36(9):883-90. PubMed ID: 7591613
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myocardial and coronary vessel dysfunction in diabetes I patients].
    Konduracka E; Galicka-Latała D; Piwowarska W; Sieradzki J
    Przegl Lek; 2002; 59(7):514-8. PubMed ID: 12516240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Microangiopathic complications in type 2 diabetes].
    Strojek K; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategy of investigation of coronary artery disease in diabetes: from screening to suspicion of acute coronary syndromes].
    Machecourt J; Vanzetto G; Fagret D
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():41-6. PubMed ID: 15666481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of extracranial vascular processes and risk profile in patients with peripheral and coronary artery disease].
    Steinke W; Al-Deeb S; Hennerici M
    Vasa; 1987; 16(3):283-90. PubMed ID: 3660940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Life style illness arteriosclerosis. Antioxidants at the heart of the issue].
    Wepner U
    MMW Fortschr Med; 2003 Oct; 145(43):10. PubMed ID: 14652929
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic macroangiopathy--therapy and prevention].
    Oikawa S
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():146-50. PubMed ID: 12386986
    [No Abstract]   [Full Text] [Related]  

  • 13. The broad-reaching power of statins. These "wonder" drugs offer an astounding range of benefits to treat--and prevent--heart disease.
    Health News; 2006 Apr; 12(4):3-5. PubMed ID: 16572517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary and secondary prevention: physical activity].
    Schuler G
    Z Kardiol; 2002; 91 Suppl 2():30-9. PubMed ID: 12436763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Position paper on primary prevention of cardiovascular diseases. Current edition of 25 March 2003 by the governing body of the German Society of Cardiology-Heart- and Cardiovascular Research, revised by request of the governing body via the Prevention Project Group].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G
    Z Kardiol; 2004; 93 Suppl 2():II43-5. PubMed ID: 15021996
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes and coronary heart disease frequently appear together. New guidelines regulate therapy and prevention].
    MMW Fortschr Med; 2006 Oct; 148(41):10-1. PubMed ID: 17190248
    [No Abstract]   [Full Text] [Related]  

  • 17. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower cholesterol to lower heart risk.
    Clark WL
    Diabetes Self Manag; 2004; 21(3):19, 21-2, 25. PubMed ID: 15206362
    [No Abstract]   [Full Text] [Related]  

  • 19. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone.
    Biesenbach G; Königsrainer A; Gross C; Margreiter R
    Transpl Int; 2005 Sep; 18(9):1054-60. PubMed ID: 16101726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.
    Lüscher TF; Creager MA; Beckman JA; Cosentino F
    Circulation; 2003 Sep; 108(13):1655-61. PubMed ID: 14517152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.